Tuning the Cytotoxicity of Bis-Phosphino-Amines Ruthenium(II) Para-Cymene Complexes for Clinical Development in Breast Cancer

Despite some limitations such as long-term side effects or the potential presence of intrinsic or acquired resistance, platinum compounds are key therapeutic components for the treatment of several solid tumors. To overcome these limitations, maintaining the same efficacy, organometallic ruthenium(I...

ver descrição completa

Detalhes bibliográficos
Autores principales: Domínguez-Jurado, Elena, Cimas, Francisco J., Castro-Osma, José Antonio, Juan, Alberto, Lara-Sánchez, Agustín, Rodríguez-Diéguez, Antonio, Shafir, Alexandr, Ocaña, Alberto, Alonso-Moreno, Carlos
Formato: Online Artigo Texto
Idioma:English
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539368/
https://www.ncbi.nlm.nih.gov/pubmed/34683852
http://dx.doi.org/10.3390/pharmaceutics13101559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539368/
https://www.ncbi.nlm.nih.gov/pubmed/34683852
http://dx.doi.org/10.3390/pharmaceutics13101559

Registos relacionados